News | April 26, 2023
Siegfried breaks ground on new R&D center for drug substances in Switzerland
The R&D Center significantly increases Siegfried’s R&D capacity to drive further growth
The R&D Center significantly increases Siegfried’s R&D capacity to drive further growth
To enable company to be future-ready by tapping potential in CDMO space
Cooperative agreement with U.S. Government to advance U.S. biopharma industry and ensure pandemic preparedness
For anaemia control in children (0-19 years) & resolves for Call to Action in this direction
This clinical study will inform operational logistics and use of AV7909 should an anthrax emergency occur.
This industry-academia collaboration will provide students with an opportunity to participate in research activities with multiple international universities and scientists
Novavax' vaccine is the first protein-based COVID-19 vaccine authorized in the U.S.
The £118 million Mazumdar-Shaw Advanced Research Centre (ARC) will be the creative and collaborative heart of cross-disciplinary research at the University of Glasgow.
Marinus has broadened inclusion criteria in the RAISE trial to allow for enrollment of patients previously treated with IV anesthesia.
Construction will begin in early 2023, and the plant is scheduled to go onstream in 2025
Subscribe To Our Newsletter & Stay Updated
